Ayrton Capital’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,349
Closed -$276K 79
2023
Q1
$276K Buy
+4,349
New +$276K 0.99% 19